SRS Capital Advisors »

Humacyte shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $7.4k 1.5k 5.05
2024-09-30 $8.5k 1.6k 5.44
2024-06-30 $3.8k 783 4.80

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Tips Etf (SCHP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Humacyte

BlackRock
Vanguard Group
State Street Corporation
Woodline Partners
Geode Capital Management
Susquehanna International
UBS Group
Two Sigma Investments
Millennium Management
Northern Trust
Brevan Howard Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Morgan Stanley
Private Advisor

View all funds holding Humacyte